The encounter of elevated high-density lipoprotein cholesterol and high blood pressure lowers life expectancy.
von Eckardstein A.
Eur J Prev Cardiol. 2023 Aug 1;30(10):948-950. doi: 10.1093/eurjpc/zwad108.
Non-high-density lipoprotein cholesterol: why lower is better.
Garg R, Vasamreddy CR, Blumenthal RS.
Prev Cardiol. 2005 Summer;8(3):173-7. doi: 10.1111/j.1520-037x.2005.4077.x.
Sex differences in lipids: A life course approach.
Holven KB, Roeters van Lennep J.
Atherosclerosis. 2023 Nov;384:117270. doi: 10.1016/j.atherosclerosis.2023.117270. Epub 2023 Sep 1.
Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol.
Luo Y, Peng D.
J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231189597. doi: 10.1177/10742484231189597.
Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol.
Williams PT.
Lifestyle Genom. 2021;14(1):1-19. doi: 10.1159/000511421. Epub 2020 Dec 9.
Neutrophil to high-density lipoprotein cholesterol ratio, a novel risk factor associated with acute ischemic stroke.
Yu L, Ma K, Hao J, Zhang B.
Medicine (Baltimore). 2023 Jun 30;102(26):e34173. doi: 10.1097/MD.0000000000034173.
Low High-Density Lipoprotein Cholesterol and High White Blood Cell Counts: A Mendelian Randomization Study.
Harsløf M, Pedersen KM, Nordestgaard BG, Afzal S.
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):976-987. doi: 10.1161/ATVBAHA.120.314983. Epub 2020 Dec 17.
Cholesterol transfer to high-density lipoprotein in obesity and the effects of weight loss after bariatric surgery.
de Oliveira WPC, Freitas FR, Costa MT, Silva AO, de Cleva R, Kalil Filho R, Santo MA, Maranhão RC.
Clin Obes. 2024 Oct;14(5):e12688. doi: 10.1111/cob.12688. Epub 2024 Jun 29.
High-density Lipoprotein Cholesterol and the Risk of Future Retinal Artery Occlusion Development: A Nationwide Cohort Study.
Hwang S, Kang SW, Choi KJ, Son KY, Lim DH, Shin DW, Kim K, Kim SJ.
Am J Ophthalmol. 2022 Mar;235:188-196. doi: 10.1016/j.ajo.2021.09.027. Epub 2021 Oct 6.
Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.
Aslibekyan S, Straka RJ, Irvin MR, Claas SA, Arnett DK.
Expert Rev Cardiovasc Ther. 2013 Mar;11(3):355-64. doi: 10.1586/erc.12.134.
